Hereditary spastic paraplegia associated with a rare endoplasmic reticulum lipid raft-associated protein 2 mutation
Keywords:Cerebral palsy, Endoplasmic reticulum lipid raft-associated protein 2, Gene, Spastic paraplegia
Hereditary spastic paraplegia (HSP) is a clinically and genetically heterogeneous group of neurological disorders that are characterized by progressive spasticity of the lower extremities. It can present as pure form or complex form. It can be present from infancy to adulthood, but majority in adult population. Childhood onset HSP must be differentiated from common conditions like cerebral palsy, neurodegenerative disorders and metabolic disorders. Many patients with pediatric HSP are mistakenly diagnosed with cerebral palsy. In children with spastic paraplegia in whom no acquired cause identified, HSP should be considered. Here we diagnosed a 6-year-old boy with HSP who presented with progressive spastic paraplegia, intellectual disability, seizures, joint contractures and cataract. His genetic study revealed exonic deletion of endoplasmic reticulum lipid raft-associated protein gene, which is associated with complicated Autosomal recessive HSP 18 (SPG18). HSP 18 was rarely described in literature.
Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 2008;7(12):1127-38.
Stocking A. Contributions to the pathology of the spinal cord. Arch für Psychiatr Nervenkrankh. 1880;10:676-717.
Freud S. Über familiäre Formen von cerebralen Diplegien. Neurol Zentralblatt. 1893;12:512-5.
Finsterer J, Löscher W, Quasthoff S, Wanschitz J, Auer-Grumbach M. Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. J Neurol Sci. 2012;318:1-18.
McDermott C, White K, Bushby K, Shaw P. Hereditary spastic paraparesis: A review of new developments. J Neurol Neurosurg Psychiatry. 2000;69:150-60.
Appleton RE, Farrell K, Dunn HG. ‘Pure’ and ‘complicated’ forms of hereditary spastic paraplegia presenting in childhood. Dev Med Child Neurol. 1991;33:304‑12.
de Bot ST, van de Warrenburg BP, Kremer HP, Willemsen MA. Child neurology: Hereditary spastic paraplegia in children. Neurol. 2010;75:e75‑9.
Koul R, Al‑Murshedi FM, Al‑Azri FM, Mani R, Abdelrahim RA, Koul V, et al. Clinical spectrum of hereditary spastic paraplegia in children: a study of 74 cases. Sultan Qaboos. Univ Med J. 2013;13:371‑9.
Kamate M, Detroja M. Clinico-investigative profile of hereditary spastic paraplegia in children. Ann Indian Acad Neurol. 2019;22:341-4.
Lo Giudice T, Lombardi F, Santorelli FM, Kawarai T, Orlacchio A. Hereditary spastic paraplegia: Clinical‑genetic characteristics and evolving molecular mechanisms. Exp Neurol. 2014;261:518‑39.
Ashwal S, Russman BS, Blasco PA, Miller G, Sandler A, Shevell M, et al. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the quality standards subcommittee of the American Academy of neurology and the practice committee of the child neurology society. Neurol. 2004;62(6):851-63.
de Souza PVS, de Rezende Pinto WBV, de Rezende Batistella GN, Bortholin T, Oliveira ASB. Hereditary spastic paraplegia: clinical and genetic hallmarks. Cerebell. 2017;16:525-51.
Faber I, Servelhere KR, Martinez AR, D’Abreu A, Lopes-Cendes I, França Junior MC. Clinical features and management of hereditary spastic paraplegia. Arq Neuropsiquiatr. 2014;72(3):219-26.
Tesson C, Koht J, Stevanin G. Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology. Hum Genet. 2015;134:511-38.
Yildirim Y, Orhan EK, Iseri SA. A frameshift mutation of ERLIN2 in recessive intellectual disability, motor dysfunction and multiple joint contractures. Hum Mol Genet 2011;20:1886-92.
Alazami AM, Adly N, Al Dhalaan H, Alkuraya FS. A nullimorphic ERLIN2 mutation defines a compli cated hereditary spastic paraplegia locus (SPG18). Neurogeneti. 2011;12:333-6.